Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM36 (TRIM36)

Target
TRIM36
Molecular classification
Enzyme (E3 ubiquitin-protein ligase), TRIM (Tripartite motif) family, RING-type E3 ubiquitin ligase
01

Overview

E3 ubiquitin-protein ligase TRIM36 is a cytoskeletal-associated enzyme of the tripartite motif (TRIM) family, characterized by a RING finger, B-box type 1 and 2, and coiled-coil domains, with prominent roles in ubiquitinating target proteins and regulating their degradation via the proteasome[1][2][3]. TRIM36 is notably involved in cell cycle regulation, chromosome segregation, and organization of the microtubule cytoskeleton, as well as being essential for embryonic dorso–ventral axis formation and neural tube closure in early development[1]. It is also highly expressed in testis, participating in the acrosome reaction during spermatogenesis[1]. Loss-of-function mutations result in neural tube defects such as anencephaly, and disruptions in its activity are linked to cellular proliferation and apoptotic changes, hinting at possible tumor suppressor or oncogenic functions depending on context[1][2][3]. There are no known drugs directly targeting TRIM36 as of current knowledge.

Other names
Tripartite motif-containing protein 36HaprinRING finger protein 98RNF98Zinc-binding protein Rbcc728ANPHANPH1RBCC728
02

Mechanism of action

For hypothetical drugs: Inhibition or modulation of E3 ligase activity (would affect substrate ubiquitination and degradation)

03

Biological functions

Ubiquitination (post-translational modification)Proteasomal degradation of substrate proteinsRegulation of microtubule cytoskeleton organizationCell cycle and chromosome segregationMitotic spindle formation and cytokinesisEmbryonic development, particularly dorso–ventral axis formationAcrosome reaction in spermatogenesis
04

Disease associations

Neural tube defects (e.g., anencephaly)Potential role in cancer (due to microtubule and cell cycle regulation)Possible relevance in male infertility (via spermatogenesis defects)
05

Safety considerations

Embryonic development risks (given its crucial role in dorso-ventral axis specification and neural tube closure)Potential effects on fertility (due to role in spermatogenesis)Broad cytoskeletal impact (possible cell cycle and mitotic defects if targeted)
06

Biomarkers

Mutations in TRIM36 for neural tube defects, such as anencephaly

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM36 (TRIM36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM36 (TRIM36).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call